BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21729304)

  • 21. Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer.
    Inanç M; Er O; Karaca H; Berk V; Ozkan M; Saraymen R; Elmalı F
    Med Oncol; 2012 Dec; 29(5):3119-24. PubMed ID: 22580817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
    Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased serum platelet derived growth factor BB levels in acute and increased in chronic pancreatitis.
    Stojek M; Adrych K; Rojek L; Smoczynski M; Sledzinski T; Szrok S; Swierczynski J
    World J Gastroenterol; 2014 Sep; 20(36):13127-32. PubMed ID: 25278706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutations.
    Celano M; Sponziello M; Tallini G; Maggisano V; Bruno R; Dima M; Di Oto E; Redler A; Durante C; Sacco R; Filetti S; Russo D
    Endocrine; 2013 Feb; 43(1):147-53. PubMed ID: 22815044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance).
    Nixon AB; Pang H; Starr MD; Friedman PN; Bertagnolli MM; Kindler HL; Goldberg RM; Venook AP; Hurwitz HI;
    Clin Cancer Res; 2013 Dec; 19(24):6957-66. PubMed ID: 24097873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment to Posttreatment Hypoxia Inducible Factor-1α Ratios as a Potentially Predictive Marker for First-Line Treatment in Nonsmall Cell Lung Cancer Patients without Known Driver Mutations.
    Hu M; Zhang T; Gu M; Li J; Zhang H; Wang Q; Hu F; Yang Y; Li B
    Genet Test Mol Biomarkers; 2020 Dec; 24(12):798-803. PubMed ID: 33347392
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.
    Sawada M; Oishi T; Komatsu H; Sato S; Chikumi J; Nonaka M; Kudoh A; Osaku D; Harada T
    Int J Clin Oncol; 2019 Dec; 24(12):1612-1619. PubMed ID: 31236742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Secord AA; Darcy KM; Hutson A; Lee PS; Havrilesky LJ; Grace LA; Berchuck A;
    Gynecol Oncol; 2007 Jul; 106(1):221-32. PubMed ID: 17481705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in circulating pro-angiogenic and pro-inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega-3 fish oil.
    Arshad A; Chung WY; Steward W; Metcalfe MS; Dennison AR
    HPB (Oxford); 2013 Jun; 15(6):428-32. PubMed ID: 23458624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-Dimer Could Be a Surrogate Postoperative Prognostic Marker of Resectable Pancreatic Cancer.
    Watanabe A; Harimoto N; Araki K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Yamanaka T; Hagiwara K; Hoshino K; Muranushi R; Shirabe K
    Pancreas; 2020 Apr; 49(4):e36-e38. PubMed ID: 32282780
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma.
    Klatte T; Böhm M; Nelius T; Filleur S; Reiher F; Allhoff EP
    BJU Int; 2007 Jul; 100(1):209-14. PubMed ID: 17428240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.
    Santini D; Vincenzi B; Dicuonzo G; Avvisati G; Massacesi C; Battistoni F; Gavasci M; Rocci L; Tirindelli MC; Altomare V; Tocchini M; Bonsignori M; Tonini G
    Clin Cancer Res; 2003 Aug; 9(8):2893-7. PubMed ID: 12912933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.
    Ninck S; Reisser C; Dyckhoff G; Helmke B; Bauer H; Herold-Mende C
    Int J Cancer; 2003 Aug; 106(1):34-44. PubMed ID: 12794754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes.
    Yin JB; Li N; Cui MM; Wang X; Wang RT
    BMC Gastroenterol; 2020 May; 20(1):143. PubMed ID: 32393273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer.
    Schölch S; Bogner A; Bork U; Rahbari M; Győrffy B; Schneider M; Reissfelder C; Weitz J; Rahbari NN
    Sci Rep; 2019 Jul; 9(1):10921. PubMed ID: 31358848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables.
    Rykala J; Przybylowska K; Majsterek I; Pasz-Walczak G; Sygut A; Dziki A; Kruk-Jeromin J
    Pathol Oncol Res; 2011 Dec; 17(4):809-17. PubMed ID: 21560015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma inflammatory cytokines and survival of pancreatic cancer patients.
    Babic A; Schnure N; Neupane NP; Zaman MM; Rifai N; Welch MW; Brais LK; Rubinson DA; Morales-Oyarvide V; Yuan C; Zhang S; Poole EM; Wolpin BM; Kulke MH; Barbie DA; Wong K; Fuchs CS; Ng K
    Clin Transl Gastroenterol; 2018 Apr; 9(4):145. PubMed ID: 29691365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AB0 blood group and prognosis in patients with pancreatic cancer.
    Rahbari NN; Bork U; Hinz U; Leo A; Kirchberg J; Koch M; Büchler MW; Weitz J
    BMC Cancer; 2012 Jul; 12():319. PubMed ID: 22838843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenic biomarkers and healing of living cellular constructs.
    Morelli T; Neiva R; Nevins ML; McGuire MK; Scheyer ET; Oh TJ; Braun TM; Nör JE; Bates D; Giannobile WV
    J Dent Res; 2011 Apr; 90(4):456-62. PubMed ID: 21248359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability of the Composition of Growth Factors and Cytokines in Platelet-Rich Plasma From the Knee With Osteoarthritis.
    Ha CW; Park YB; Jang JW; Kim M; Kim JA; Park YG
    Arthroscopy; 2019 Oct; 35(10):2878-2884.e1. PubMed ID: 31604507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.